ALDESLEUKIN - INJECTION
PHONETIC PRONUNCIATION: (AL-des-LOO-kin)
COMMON BRAND NAME(S): Proleukin
GENERIC NAME(S): aldesleukin
Uses
USES: Aldesleukin is used to treat advanced forms of kidney or skin cancer (cancer that has spread to other parts of the body). This medication is the same as a substance that your body normally makes (interleukin-2). In the body, this drug is thought to work by affecting the body's natural defenses (immune system). This effect slows or stops cancer cell growth.
How to use ALDESLEUKIN - INJECTION
HOW TO USE: This medication is given by injection into a vein over 15 minutes by a health care professional. It may also be given in other ways as directed by your doctor. This medication is usually given every 8 hours for 5 days in a row. However, your doctor may decide to delay or stop your treatment depending on how you respond to this drug. After this treatment period, you will be given time to rest and recover before getting more of this medication. A course of therapy may include up to 28 doses of this medication. To make sure that you receive each scheduled dose as directed, it is important to keep all of your medical appointments while receiving this medication. Depending on your response, your doctor may decide that a second course would be helpful. Dosage is based on your medical condition, weight, response to treatment, and your side effects.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for ALDESLEUKIN - INJECTION
Aldesleukin injection, also known as IL-2, is used to treat advanced kidney cancer (renal cell carcinoma) and metastatic melanoma.
Aldesleukin injection works by stimulating the body's immune system to attack and destroy cancer cells.
Aldesleukin injection is administered as an intravenous infusion (IV) in a healthcare setting under the supervision of a healthcare professional.
Common side effects of Aldesleukin injection may include flu-like symptoms such as fever, chills, fatigue, nausea, vomiting, diarrhea, and loss of appetite. It can also cause low blood pressure and respiratory problems.
Aldesleukin injection is usually given every 8 hours for up to 14 consecutive doses, followed by a rest period of up to 9 days. This cycle may be repeated for a total of 28 doses or until the disease progression occurs.
The effects of Aldesleukin injection may vary, but it typically takes several weeks or months to see a response. Some patients may experience a complete or partial response, while others may not respond to the treatment.
Aldesleukin injection is contraindicated in patients with hypersensitivity to the drug or any of its components. It should be used with caution in patients with pre-existing medical conditions such as heart disease, liver or kidney impairment, or autoimmune disorders.
Aldesleukin injection should not be used during pregnancy unless the potential benefits outweigh the potential risks. It is also not recommended for use while breastfeeding, as it may be excreted in breast milk and could harm the nursing baby.
The safety and effectiveness of Aldesleukin injection in children have not been established, and it is primarily used in adults for the treatment of advanced kidney cancer and metastatic melanoma.
The treatment with Aldesleukin injection typically consists of a series of cycles, with each cycle lasting 9 days. The cycles are usually separated by a period of rest.
Aldesleukin injection can be effective in treating certain cancers, but it does not guarantee a cure. The response to treatment varies from person to person, and some individuals may experience a complete or partial response, while others may not respond at all.
Aldesleukin injection should not be used in individuals with a history of severe heart or lung disease, an autoimmune disorder, or organ transplant. It should also be used with caution in patients with pre-existing medical conditions or those taking certain medications.
The frequency of Aldesleukin injection administration depends on the specific treatment plan determined by your healthcare provider. It is typically given on a specified schedule, which may include multiple cycles of treatment.
Yes, Aldesleukin injection can be used in combination with other cancer treatments such as surgery, radiation therapy, or targeted therapy, as determined by your healthcare provider. This combination approach may improve the overall effectiveness of treatment.
Warning
WARNING: Aldesleukin must be given in a hospital setting by a health care professional. It must be used with extreme caution in patients with heart or lung problems. Infrequently, this medication can cause capillary leak syndrome (CLS), a serious condition that can sometimes be fatal. If you develop any of the following signs of CLS, tell your doctor right away: swelling, severe dizziness, fainting, irregular heartbeat, chest pain (angina), trouble breathing, signs of kidney problems (such as change in the amount of urine), mental/mood changes, severe stomach/abdominal pain, black stools. Aldesleukin can also make you more likely to get serious infections. Before using this drug, tell your doctor if you currently have any infections. Also, tell your doctor right away if you develop any of the following signs of infection: persistent sore throat, fever. Rarely, this drug may cause a loss of consciousness. If this drug makes you unusually sleepy, stop using it and tell your doctor right away.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet